Kuwait Antiviral Drugs Market Size & Outlook, 2022-2030
Kuwait antiviral drugs market, 2018-2030 (US$M)
Related Markets
Kuwait antiviral drugs market highlights
- The Kuwait antiviral drugs market generated a revenue of USD 197.0 million in 2022 and is expected to reach USD 130.1 million by 2030.
- The Kuwait market is expected to grow at a CAGR of -5.1% from 2023 to 2030.
- In terms of segment, hiv was the largest revenue generating application in 2022.
- HIV is the most lucrative application segment registering the fastest growth during the forecast period.
Antiviral drugs market data book summary
| Market revenue in 2022 | USD 197.0 million |
| Market revenue in 2030 | USD 130.1 million |
| Growth rate | -5.1% (CAGR from 2022 to 2030) |
| Largest segment | Hiv |
| Fastest growing segment | HIV |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | HIV, Hepatitis, Herpes, Influenza |
| Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.3% of the global antiviral drugs market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia antiviral drugs market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 134.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiviral Drugs Market Scope
Antiviral Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait antiviral drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 25.38% in 2022. Horizon Databook has segmented the Kuwait antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
Several multinational and regional pharmaceutical companies are likely to be active in the Kuwaiti market offering antiviral drugs majorly in the winter season when there is a higher possibility of seasonal flu and the spread of viral infections. Several multinational players are focusing on developing and distributing antiviral drugs in Kuwait market owing to the unmet medical need present in the country.
For instance, in July 2020, Fujifilm Holdings Corp., headquartered in Japan, announced the launch of a clinical study of Avigan, an antiviral drug in Kuwait. Furthermore, government initiatives and investments in the fields of anti-infectives and pharmaceuticals are propelling the growth of the overall market in the country.
Reasons to subscribe to Kuwait antiviral drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait antiviral drugs market databook
-
Our clientele includes a mix of antiviral drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait antiviral drugs market size, by application, 2018-2030 (US$M)
Kuwait Antiviral Drugs Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
